과제정보
This study was supported by the Biomedical Research Institute, Jeonbuk National University Hospital, and the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (NRF-2019R1A2C1003454 and 2020R1I1A1A01054100).
참고문헌
- Privette LM and Petty EM (2008) CHFR: a novel mitotic checkpoint protein and regulator of tumorigenesis. Transl Oncol 1, 57-64 https://doi.org/10.1593/tlo.08109
- Carvajal RD, Tse A and Schwartz GK (2006) Aurora kinases: new targets for cancer therapy. Clin Cancer Res 12, 6869-6875 https://doi.org/10.1158/1078-0432.CCR-06-1405
- Yu X, Minter-Dykhouse K, Malureanu L et al (2005) Chfr is required for tumor suppression and Aurora A regulation. Nat Genet 37, 401-406 https://doi.org/10.1038/ng1538
- Tang A, Gao K, Chu L, Zhang R, Yang J and Zheng J (2017) Aurora kinases: novel therapy targets in cancers. Oncotarget 8, 23937-23954 https://doi.org/10.18632/oncotarget.14893
- Du R, Huang C, Liu K, Li X and Dong Z (2021) Targeting AURKA in cancer: molecular mechanisms and opportunities for cancer therapy. Mol Cancer 20, 15 https://doi.org/10.1186/s12943-020-01305-3
- Jemal A, Center MM, DeSantis C and Ward EM (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 19, 1893-1907 https://doi.org/10.1158/1055-9965.EPI-10-0437
- Siegel R, Naishadham D and Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63, 11-30 https://doi.org/10.3322/caac.21166
- Mathias RA, Gopal SK and Simpson RJ (2013) Contribution of cells undergoing epithelial-mesenchymal transition to the tumour microenvironment. J Proteomics 78, 545-557 https://doi.org/10.1016/j.jprot.2012.10.016
- Thiery JP and Sleeman JP (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7, 131-142 https://doi.org/10.1038/nrm1835
- Batlle E, Sancho E, Franci C et al (2000) The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2, 84-89 https://doi.org/10.1038/35000034
- Usman S, Waseem NH, Nguyen TKN et al (2021) Vimentin is at the heart of epithelial mesenchymal transition (emt) mediated metastasis. Cancers (Basel) 13, 4985 https://doi.org/10.3390/cancers13194985
- Parekh DB, Ziegler W and Parker PJ (2000) Multiple pathways control protein kinase C phosphorylation. EMBO J 19, 496-503 https://doi.org/10.1093/emboj/19.4.496
- Tarafdar A and Michie AM (2014) Protein kinase C in cellular transformation: a valid target for therapy? Biochem Soc Trans 42, 1556-1562 https://doi.org/10.1042/BST20140255
- Masur K, Lang K, Niggemann B, Zanker KS and Entschladen F (2001) High PKC alpha and low E-cadherin expression contribute to high migratory activity of colon carcinoma cells. Mol Biol Cell 12, 1973-1982 https://doi.org/10.1091/mbc.12.7.1973
- Noh EM, Lee YR, Hong OY, Jung SH, Youn HJ and Kim JS (2015) Aurora kinases are essential for PKC-induced invasion and matrix metalloproteinase-9 expression in MCF-7 breast cancer cells. Oncol Rep 34, 803-810 https://doi.org/10.3892/or.2015.4027
- Serova M, Ghoul A, Benhadji KA et al (2006) Preclinical and clinical development of novel agents that target the protein kinase C family. Semin Oncol 33, 466-478 https://doi.org/10.1053/j.seminoncol.2006.04.009
- Julien S, Puig I, Caretti E et al (2007) Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene 26, 7445-7456 https://doi.org/10.1038/sj.onc.1210546
- Nam EH, Lee Y, Moon B, Lee JW and Kim S (2015) Twist1 and AP-1 cooperatively upregulate integrin alpha5 expression to induce invasion and the epithelial-mesenchymal transition. Carcinogenesis 36, 327-337 https://doi.org/10.1093/carcin/bgv005
- D'Assoro AB, Haddad T and Galanis E (2015) Aurora-A kinase as a promising therapeutic target in cancer. Front Oncol 5, 295 https://doi.org/10.3389/fonc.2015.00295
- D'Assoro, AB, Liu T, Quatraro C et al (2014) The mitotic kinase Aurora-A promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERalpha(+) breast cancer cells. Oncogene 33, 599-610 https://doi.org/10.1038/onc.2012.628
- Goos JA, Coupe VM, Diosdado B et al (2013) Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis. Br J Cancer 109, 2445-2452 https://doi.org/10.1038/bjc.2013.608
- Steeghs N, Eskens FA, Gelderblom H et al (2009) Phase I pharmacokinetic and pharmacodynamic study of the aurora kinase inhibitor danusertib in patients with advanced or metastatic solid tumors. J Clin Oncol 27, 5094-5101 https://doi.org/10.1200/JCO.2008.21.6655
- Bauvois B (2012) New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. Biochim Biophys Acta 1825, 29-36
- Stetler-Stevenson WG (1999) Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Invest 103, 1237-1241 https://doi.org/10.1172/JCI6870
- Nomura A, Majumder K, Giri B et al (2016) Inhibition of NF-kappa B pathway leads to deregulation of epithelial-mesenchymal transition and neural invasion in pancreatic cancer. Lab Invest 96, 1268-1278 https://doi.org/10.1038/labinvest.2016.109
- Julien S, Puig I, Caretti E et al (2007) Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene 26, 7445-7456 https://doi.org/10.1038/sj.onc.1210546
- Bakiri L, Macho-Maschler S, Custic I (2015) Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression. Cell Death Differ 22, 336-350 https://doi.org/10.1038/cdd.2014.157